A Randomized, Open Label, Phase II Trial of Bevacizumab Plus Weekly Paclitaxel Followed by Bevacizumab Monotherapy Maintenance Versus Weekly Paclitaxel Followed by Observation in Patients With Relapsed Ovarian Sex-cord Stromal Tumours
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2019
At a glance
- Drugs Bevacizumab (Primary) ; Paclitaxel (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- Acronyms ALIENOR
- 25 Feb 2019 Status changed from active, no longer recruiting to completed.
- 14 Mar 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2017.
- 14 Mar 2017 Status changed from recruiting to active, no longer recruiting.